| ID | 2038 |
|---|
| No | 2038 |
|---|
| Brand Name | CEFO - L 200 MG |
|---|
| Ingredients | CEFIXIME TRIHYDRATE USP 228.48 MG EQ.TO CEFIXIME ANHYDROUS 200 MG, LACTIC ACID BACILLUS 60 MILLION SPORES 35 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | ALU-ALU BLISTER |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | 10'S/BLISTER, 10 BLISTERS/BOX |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | RESPIRATORY TRACT INFECTIONS, OTITIS MEDIA, SEQUENTIAL TREATMENT AFTER INITIAL I.V. CHEMOTHERAPY AFTER PARENTERAL CEPHALOSPORIN, URINARY TRACT INFECTIONS, GONORRHOEA, TYPHOID FEVER |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | ORANGE COLORED, CIRCULAR, FLAT BEVELED EDGED, UNCOATED TABLET HAVING PLAIN SURFACE ON BOTH THE SIDES |
|---|
| Note | |
|---|
| License Owner | PALAMY PHARMA CO., LTD |
|---|
| Manufacturer | MEDLEY PHARMACEUTICALS LTD. |
|---|
| Country | INDIA |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 07 I 3145/08 |
|---|
| FDD Registration Date | 19/04/2023 |
|---|
| Expiry Date | 18/04/2026 |
|---|
